Search

γδ T cells are a distinct subset of T cells whose T cell receptors consist of γ chains and δ chains, different from conventional αβ T cells. γδ T cells are considered as a member of the innate immunity because of their non-MHC restricted antigen recognition, rapid response to invading pathogens and sense early changes of malignant cells. Upon activation, they can further promote the activation of adaptive immune cells, such as T cells and B cells, by secreting various cytokines. Thus, γδ T cells are regarded as a bridge between innate immunity and acquired immunity. γδ T cells are involved in a variety of immune response processes, including immune defense and immune surveillance against infection and tumorigenesis. γδ T cells recognize multiple tumor-associated antigens or molecules in T cell receptors (TCRs)-dependent and natural killer cell receptors (NKRs)-dependent ways. γδ T cells not only display a direct killing capacity on a variety of tumors, but also exert anti-tumor immune responses indirectly by facilitating the function of other immune cells, such as dendritic cells (DCs), B cells and CD8+ T cells. In this review, we summarize the major subpopulations, the tumor recognition mechanisms, and the anti-tumor effects of human γδ T cells, particularly the potential of γδ T cells for cancer immunotherapy.

In this study, we report the complete mitochondrial genome of Harpalus sinicus (occasionally named as the Chinese ground beetle) which is the first mitochondrial genome for Harpalus. The mitogenome is 16,521 bp in length, comprising 37 genes, and a control region. The A + T content of the mitogenome is as high as 80.6%. A mitochondrial origins of light-strand replication (OL)-like region is found firstly in the insect mitogenome, which can form a stem-loop hairpin structure. Thirteen protein-coding genes (PCGs) share high homology, and all of them are under purifying selection. All tRNA genes (tRNAs) can be folded into the classic cloverleaf secondary structures except tRNA-Ser (GCU), which lacks a dihydrouridine (DHU) stem. The secondary structure of two ribosomal RNA genes (rRNAs) is predicted based on previous insect models. Twelve types of tandem repeats and two stem-loop structures are detected in the control region, and two stem-loop structures may be involved in the initiation of replication and transcription. Additionally, phylogenetic analyses based on mitogenomes suggest that Harpalus is an independent lineage in Carabidae, and is closely related to four genera (Abax, Amara, Stomis, and Pterostichus). In general, this study provides meaningful genetic information for Harpalus sinicus and new insights into the phylogenetic relationships within the Carabidae.

Decorative ornamental plants have been applied as hyperaccumulators/phytoremediators to a wide spectrum of heavy metal contaminants. In this study, pot culture experiments were conducted to investigate the Sn tolerance and accumulation in Impatiens balsamina L., Mirabilis jalapa L. and Tagetes erecta L., in order to assess the possibility of these three ornamental plants to be used as phytoremediators of Sn-contaminated soil. Results show that all three plants exhibited strong tolerance to Sn contamination, and no significant visual toxicity was observed for all three plants grown under most of the Sn treatments. The amount of Sn accumulated in the three plants was positively correlated with the Sn concentration in the soil. The order of the Sn accumulative capacity was Impatiens balsamina &gt, Mirabilis jalapa &gt, Tagetes erecta. Impatiens balsamina and Tagetes erecta showed a low translocation ability (TF) (&lt, 1), and the roots accumulated the highest Sn concentration, but Impatiens balsamina showed a relatively high bioconcentration factor (BCF, Sn concentration in each part &gt, 100 mg/kg after Sn treatment of 500 mg/kg). Meanwhile, the TF of Mirabilis jalapa was &gt, 1, and the fluorescence accumulated the most Sn. In combination with the adaptation to high concentrations of various heavy metals, these three ornamental plants are potential candidates for Sn mining tailings or contaminated soil.

A novel integrated electrode structure was designed and synthesized by direct electrodepositing of Cu&ndash, Sn alloy anode materials on the Celgard 2400 separator (Cel-CS electrode). The integrated structure of the Cel-CS electrode not only greatly simplifies the battery fabrication process and increases the energy density of the whole electrode, but also buffers the mechanical stress caused by volume expansion of Cu&ndash, Sn alloy active material, thus, effectively preventing active material falling off from the substrate and improving the cycle stability of the electrode. The Cel-CS electrode exhibits excellent cycle performance and superior rate performance. A capacity of 728 mA&middot, h&middot, g&minus, 1 can be achieved after 250 cycles at the current density of 100 mA&middot, 1. Even cycled at a current density of 5 A&middot, 1 for 650 cycles, the Cel-CS electrode maintained a specific capacity of 938 mA&middot, 1, which illustrates the potential application prospects of the Cel-CS electrode in microelectronic devices and systems.

Several recent studies have indicated that miR-30a plays critical roles in various biological processes and diseases. However, the mechanism of miR-30a participation in idiopathic pulmonary fibrosis (IPF) regulation is ambiguous. Our previous study demonstrated that miR-30a may function as a novel therapeutic target for lung fibrosis by blocking mitochondrial fission, which is dependent on dynamin-related protein1 (Drp-1). However, the regulatory mechanism between miR-30a and Drp-1 is yet to be investigated. Additionally, whether miR-30a can act as a potential therapeutic has not been verified in vivo. In this study, the miR-30a expression in IPF patients was evaluated. Computational analysis and a dual-luciferase reporter assay system were used to identify the target gene of miR-30a, and cell transfection was utilized to confirm this relationship. Ten–eleven translocation 1 (TET1) was validated as a direct target of miR-30a, and miR-30a mimic and inhibitor transfection significantly reduced and increased the TET1 protein expression, respectively. Further experimentation verified that the TET1 siRNA interference could inhibit Drp-1 promoter hydroxymethylation. Finally, miR-30a agomir was designed and applied to identify and validate the therapeutic effect of miR-30a in vivo. Our study demonstrated that miR-30a could inhibit TET1 expression through base pairing with complementary sites in the 3′untranslated region to regulate Drp-1 promoter hydroxymethylation. Furthermore, miR-30a could act as a potential therapeutic target for IPF.